| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 225.25B | 219.96B | 199.61B | 171.23B | 137.34B | 136.40B |
| Gross Profit | 39.06B | 25.28B | 38.78B | 31.05B | 26.60B | 22.04B |
| EBITDA | 12.06B | 16.44B | 16.05B | 11.99B | 16.06B | 13.46B |
| Net Income | 9.03B | 9.66B | 12.69B | 7.02B | 8.27B | 6.73B |
Balance Sheet | ||||||
| Total Assets | 219.80B | 226.92B | 217.27B | 201.27B | 185.36B | 175.41B |
| Cash, Cash Equivalents and Short-Term Investments | 63.23B | 63.84B | 47.14B | 42.45B | 37.83B | 39.09B |
| Total Debt | 59.05B | 50.58B | 57.89B | 57.93B | 30.72B | 21.48B |
| Total Liabilities | 131.56B | 135.67B | 138.27B | 132.76B | 120.14B | 113.28B |
| Stockholders Equity | 88.24B | 87.93B | 78.99B | 68.50B | 65.20B | 62.12B |
Cash Flow | ||||||
| Free Cash Flow | 41.04B | 28.33B | 16.05B | 1.04B | -3.99B | 22.22B |
| Operating Cash Flow | 52.60B | 39.54B | 27.78B | 17.75B | 12.31B | 35.32B |
| Investing Cash Flow | -40.91B | -28.63B | -23.30B | -10.45B | -10.50B | -11.17B |
| Financing Cash Flow | -14.57B | -13.10B | -12.18B | 1.05B | -3.13B | -9.63B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$242.71B | 9.90 | 18.03% | 1.95% | 43.98% | -0.46% | |
71 Outperform | HK$182.39B | 7.52 | ― | ― | ― | ― | |
64 Neutral | HK$1.01T | 24.33 | 14.29% | 1.55% | 3.62% | -22.00% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | HK$173.19B | 24.70 | 10.49% | 3.41% | 17.13% | -18.63% | |
56 Neutral | HK$122.67B | -122.26 | -3.77% | ― | 88.09% | 80.63% | |
52 Neutral | HK$142.33B | 107.16 | 1.55% | ― | -22.22% | -86.30% |